4 completed, 3 unknown, 2 recruiting, 1 not yet recruiting. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 4, Unknown 3, Recruiting 2, Not yet recruiting 1 |
Follow Vaccine: new trials by email Literature Review of Vaccine trials Research Report on Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial Two-dose M0-M2 vaccination schedule, Two-dose M0-M6 vaccination schedule - Vaccine, Varicella-zoster Virus | Phase 4 | Not yet recruiting | University Hospital, Toulouse | 160 | 2026-10-20 | 2026-09-14 |
| Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines Pneumococcal Vaccine - Vaccine, Pneumococcal Disease | Phase 4 | Recruiting | University of Alabama at Birmingham | 70 | 2026-07-01 | 2026-08-21 |
| PFAS Exposure and Immune Response to Vaccination in Adults TENIVAC - Innate Inflammatory Response, Vaccination | Phase 4 | Completed | Rutgers, The State University of New Jersey | 20 | 2024-11-04 | 2025-12-30 |
| Primary TBE Vaccination for the Elderly FSME-IMMUN Vaccine - Tick-borne Encephalitis, Vaccine | Phase 4 | Unknown | Region Örebro County | 90 | 2024-01-01 | 2023-11-18 |
| Effects of Shotblocker® and Manual Pressure on Pain Shotblocker, Manuel Pressure - Healthy Volunteers, Infant | Phase 4 | Completed | Aydin Adnan Menderes University | 102 | 2022-02-15 | 2025-02-07 |
| Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live Measles, Mumps and Rubella Combined Vaccine, Live - Immunotoxicity, Vaccine | Phase 4 | Completed | Shanghai Institute Of Biological Products | 1068 | 2021-12-23 | 2023-08-14 |
| Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma Prevenar 13 + Pneumovax 23, PREVENAR20 - Vaccine, Streptococcus Pneumoniae | Phase 4 | Recruiting | Poitiers University Hospital | 160 | 2021-09-07 | 2026-05-29 |
| Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV Coronavirus vaccine - People Living With HIV, COVID-19 | Phase 4 | Unknown | Beijing 302 Hospital | 200 | 2021-09-01 | 2021-10-20 |
| Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR sIPV+DTaP+MMR, sIPV, DTaP - Vaccine | Phase 4 | Unknown | China National Biotec Group Company Limited | 600 | 2020-11-13 | 2020-12-10 |
| Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions Cell-derived influenza vaccine, Egg-derived influenza vaccine - Seasonal Influenza, Vaccine | Phase 4 | Completed | Novartis Vaccines | 1398 | 2007-11-01 | 2016-02-17 |
COVID-19 (1) · Chickenpox (1) · Diphtheria (1) · Encephalitis, Tick-Borne (1) · Herpes Zoster (1) · Inflammation (1) · Influenza, Human (1) · Lymphoma, Non-Hodgkin (1) · Multiple Sclerosis (1) · Pain (1) · Pneumococcal Infections (1) · Tetanus (1)
Infections (6) · Virus Diseases (4) · RNA Virus Infections (3) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Actinomycetales Infections (1) · Arbovirus Infections (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1)
13-valent pneumococcal vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Diphtheria-Tetanus Vaccine (1) · FSME-IMMUN vaccine (1) · Pneumococcal Vaccines (1) · Tetanus Toxoid (1)
Aydin Adnan Menderes University (1) · Beijing 302 Hospital (1) · China National Biotec Group Company Limited (1) · Novartis Vaccines (1) · Poitiers University Hospital (1) · Region Örebro County (1) · Rutgers, The State University of New Jersey (1) · Shanghai Institute Of Biological Products (1) · University Hospital, Toulouse (1) · University of Alabama at Birmingham (1)
China (3) · France (2) · United States (2) · Germany (1) · Sweden (1) · Turkey (Türkiye) (1)
Fenyang Tang (1) · Hongxing Pan (1) · Jonathan Ciron, MD (1) · Robert Laumbach, MD (1) · Shu-juan Li, MD (1)
2025 (1)